Broadcast Date: Tuesday, February 28, 2023
from 3:00 pm to 4:30 pm (ET)

Overview:

In recent years, psychedelics have been gaining popularity when it comes to treating an array of mental health issues. With its promising medical and therapeutic benefits, psychedelic-assisted psychotherapy (PAP) is generating significant interest among policymakers, medical professionals, and the public. As it provides an alternative treatment for refractory mental health concerns, several cities in the U.S are starting to decriminalize some psychedelics.

However, the Food and Drug Administration’s (FDA) approval for psychedelic treatment is still tough. As legal challenges and the upswing of studies in this field are likely to emerge, companies and practitioners must stay in the loop.

In a LIVE Webcast, a panel of key thought leaders and practitioners will offer an in-depth discussion of psychedelic-assisted therapy. Speakers will also dig deep into its potential opportunities, risks and pitfalls, and legal developments.

Key issues that will be covered in this course are:

  • Psychedelic Therapy: Nuts and Bolts
  • Potential Opportunities of Psychedelics
  • New Shifts in Psychedelic Drug Policies in the U.S.
  • Emerging Legal Challenges
  • What Lies Ahead?

Credit:

Course Level:

Intermediate

 

Advance Preparation:

Print and review course materials

 

Method of Presentation:

Live Webcast

 

Prerequisite:

General knowledge of psychedelic therapy

 

Course Code:

1410687

 

NY Category of CLE Credit:

Areas of Professional Practice

 

Total Credits:

1.5 CLE

Speaker:

Karl P. Frederic, Partner
Windels Marx Lane & Mittendorf, LLP

Karl Frederic is a Partner in the law firm of Windels Marx Lane & Mittendorf, LLP. He conducts a multi-disciplinary practice focusing on real estate and business transactions in the pharmaceutical, healthcare and biotech industries. Over the course of his 30+ year career, he has been the lead counsel on innumerable projects requiring specialized expertise, including  the establishment of a new medical school on a former pharmaceutical research and development campus, the refit of a production facility to manufacture immunotherapy products to treat leukemia and the development of a laboratory and pilot plant for a biofabrication process to make leather without animals. In recent years, as cannabis and psychedelic therapies have reached the mainstream, his experience in these traditional areas has naturally broadened his focus to service clients in those emerging markets.

Agenda:

Karl P. Frederic, Partner

Windels Marx Lane & Mittendorf, LLP

Date & Time:

Tuesday, February 28, 2023

3:00 pm to 4:30 pm (ET)

A recording will be available to view 24-48 hours after the live date.

Materials:

Coming Soon.

Please check back again later.

Who Should Attend:

  • Health Care Lawyers
  • FDA Law Attorneys
  • General Counsel
  • Clinical Development Professionals
  • Healthcare Services Providers
  • Licensing Professionals
  • Medical Directors
  • Mental Health Counsellors
  • Risk Managers

SPEAKER

Karl P. FredericPartner
Windels Marx Lane & Mittendorf, LLP

SUBSCRIPTION PACKAGES

ALL-ACCESS PASS

View Details

CLE LAW MONTHLY

View Details

CPE FINANCE MONTHLY

View Details

Join Over 150,000 Professionals Empowering Their Careers

Learn anywhere from over 1900+ live and recorded CLE, CPE & Technology Webcasts.